An Efficient Expression cDNA Cloning Approach to Screen Human Tumors for Oncogenes

Author(s):  
A. M.-L. Chan ◽  
S. A. Aaronson
1991 ◽  
Vol 88 (12) ◽  
pp. 5167-5171 ◽  
Author(s):  
T. Miki ◽  
T. P. Fleming ◽  
M. Crescenzi ◽  
C. J. Molloy ◽  
S. B. Blam ◽  
...  

2000 ◽  
Vol 12 (12) ◽  
pp. 4318-4330 ◽  
Author(s):  
Nathalie Moragues ◽  
Philippe Ciofi ◽  
Pierrette Lafon ◽  
Marie-Francoise Odessa ◽  
Gerard Tramu ◽  
...  

1997 ◽  
Vol 56 (1-3) ◽  
pp. 56
Author(s):  
K Tesselaar
Keyword(s):  

1989 ◽  
Vol 120 (3_Suppl) ◽  
pp. S138
Author(s):  
J. FREUDENSTEIN ◽  
J. MUCHA ◽  
G. RAPP ◽  
K. H. SHEIT

2014 ◽  
Vol 40 (11) ◽  
pp. 1925 ◽  
Author(s):  
Yu-Xiang LIU ◽  
Jiang-Rong CHEN ◽  
Yan PENG ◽  
Yu HUANG ◽  
Yan ZHAO ◽  
...  

2013 ◽  
Vol 20 (4) ◽  
pp. 722-732
Author(s):  
Bing LI ◽  
Jie WANG ◽  
Chengfeng ZHANG ◽  
Jian ZHU

2017 ◽  
Vol 63 (3) ◽  
pp. 497-505
Author(s):  
Vadim Pokrovskiy ◽  
Yelena Lukasheva ◽  
Nikolay Chernov ◽  
Yelena Treshchalina

The effectiveness of L-lysine-alpha oxidase Trichoderma cf. Aureoviride Rifai BKMF-4268D (LO) on models of subcutaneous xenografts of human tumors in athymic mice as well as the effectiveness of combination therapy with known antitumor drugs: cisplatin, irinotecan, etoposide on models of P388 lymphocytic leukemia, Lewis lung (LLC) and B16 melanoma was evaluated. The intraperitoneal injection of LO in a discrete regime at doses of 150-75-75-75-75 E/kg demonstrated inhibition of growth of all studied xenografts of human tumors in athymic mice. The combination of irinotecan+LO on the LLC model gave a significant summative therapeutic benefit with an increase in mouse life expectancy up to 35%. Cisplatin and LO realized a significant (p


Sign in / Sign up

Export Citation Format

Share Document